Moreover, CD163 is implicated in the pathogenesis of various cancers, including chronic lymphocytic leukemia, multiple myeloma, meningioma, Hodgkin’s lymphoma, and colorectal cancer33–37. This evidence concerns the gene CD163 and cancer.